Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $46.8 Million - $59.5 Million
-340,111 Closed
0 $0
Q1 2022

May 26, 2022

SELL
$131.98 - $163.75 $56.5 Million - $70.1 Million
-428,002 Reduced 55.72%
340,111 $55.1 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $26.8 Million - $34 Million
-249,857 Reduced 24.54%
768,113 $104 Million
Q3 2021

Nov 02, 2021

SELL
$106.4 - $120.78 $6.93 Million - $7.87 Million
-65,129 Reduced 6.01%
1,017,970 $110 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $4.3 Million - $4.79 Million
40,896 Added 3.92%
1,083,099 $122 Million
Q1 2021

May 07, 2021

SELL
$102.3 - $112.62 $10.3 Million - $11.3 Million
-100,611 Reduced 8.8%
1,042,203 $113 Million
Q4 2020

Feb 05, 2021

BUY
$80.49 - $108.67 $897,061 - $1.21 Million
11,145 Added 0.98%
1,142,814 $122 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $5.04 Million - $5.91 Million
-58,648 Reduced 4.93%
1,131,669 $99.1 Million
Q2 2020

Sep 04, 2020

BUY
$73.37 - $98.18 $43.2 Million - $57.8 Million
588,779 Added 97.88%
1,190,317 $117 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $43.1 Million - $57.6 Million
-586,850 Reduced 49.38%
601,538 $53.3 Million
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $37.9 Million - $57.4 Million
586,850 Added 97.56%
1,188,388 $90.5 Million
Q4 2019

Feb 07, 2020

BUY
$72.13 - $90.25 $43.4 Million - $54.3 Million
601,538 New
601,538 $53.3 Million
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $3.92 Million - $4.64 Million
-43,661 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $8.99 Million - $12 Million
-97,741 Reduced 69.12%
43,661 $4.13 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $4.6 Million - $5.04 Million
-51,330 Reduced 26.63%
141,402 $13.7 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $13.5 Million - $17.2 Million
192,732
192,732 $17.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ninety One Uk LTD Portfolio

Follow Ninety One Uk LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ninety One Uk LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ninety One Uk LTD with notifications on news.